---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-007760"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2026-07-23T00:13:48+00:00"
generated_at: "2026-07-23T10:05:24.918375+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# KALA BIO files prospectus supplement for securities offering

## Summary
- Filed prospectus supplement under Rule 424(b) on July 22, 2026 for an offering of securities.
- Offering made under effective S-3 registration statement (File No. 333-295667).
- Legal opinion from Haynes and Boone, LLP on validity of securities included as Exhibit 5.1.
- No specific terms (size, price, type) of the offering disclosed in the 8-K.

## SEC filing metadata
- accession: 0001829126-26-007760
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2026-07-23T00:13:48+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000182912626007760/0001829126-26-007760-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000182912626007760/kalabio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-007760
- JSON: https://secwatch.observer/filing/0001829126-26-007760.json
- Plain text: https://secwatch.observer/filing/0001829126-26-007760.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.